MAPT and Alzheimer disease: Regular consumption of caffeine, a non-selective A2AR antagonist, protected transgenic mouse models of AD against cognitive impairment, while also mitigating amyloid and tau lesions, neuroinflammation, and oxidative stress in their brains [47, 48].